Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Completed 3Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 337INDUSTRY 40NIH 11OTHER_GOV 8NETWORK 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 49Prostatic Neoplasms 38Carcinoma, Non-Small-Cell Lung 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Neoplasms 23Multiple Myeloma 22Lymphoma 21Leukemia, Myeloid, Acute 17Colorectal Neoplasms 17Melanoma 15Lung Neoplasms 13Hodgkin Disease 11Brain Neoplasms 11Medulloblastoma 10Lymphoma, Non-Hodgkin 10Glioblastoma 10Squamous Cell Carcinoma of Head and Neck 9Pancreatic Neoplasms 9Neoplasm Metastasis 9Leukemia, Biphenotypic, Acute 9Leukemia 9Head and Neck Neoplasms 9HIV Infections 9Neuroblastoma 8Hematologic Neoplasms 8Ependymoma 8Glioma 7Carcinoma, Renal Cell 7Astrocytoma 7Wilms Tumor 6

Interventions

pertuzumab 1Trastuzumab 1Radiation 1PF-05280014 1Oxaliplatin 1Leucovorin 1Irinotecan 1Folfox protocol 1Fluorouracil 1Cetuximab 1Capecitabine 12C4 antibody 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
NETWORK × Rectal Neoplasms × 1 year × Clear all
NCT03516942 2026-05-15

Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment

Eastern Cooperative Oncology Group

Active not recruiting
565 enrolled 16 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT06205485 2026-05-12

NEO-RT

Canadian Cancer Trials Group

Phase 3 Recruiting
250 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01822444 2026-04-13

ANGIOPREDICT. ICORG 12-16, V3

Cancer Trials Ireland

Completed
76 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03259035 2026-04-09

NEO: Neoadjuvant Chemotherapy, Excision and Observation for Early Rectal Cancer

Canadian Cancer Trials Group

Phase 2 Completed
58 enrolled 12 charts
Gastrointestinal

Rectal Neoplasms

NCT03365882 2026-02-10

S1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery

SWOG Cancer Research Network

Phase 2 Completed
240 enrolled 14 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡